Flow cytometric evaluation of skin biopsies for mycosis fungoides

American Journal of Dermatopathology

Volumn 33, Issue 5, 2011, Pages 483-491

  Jokinen, Chris H ^a,b   Fromm, Jonathan R ^a   Argenyi, Zsolt B ^a   Olerud, John ^a   Wood, Brent L ^a   Greisman, Harvey A ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b Duluth Clinic   (United States)

Author keywords

CTCL; cutaneous T cell lymphoma; dermatopathology; flow cytometry; hematopathology; mycosis fungoides; skin

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD4 CD8 RATIO; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; LIGHT SCATTERING; LYMPHOCYTE SUBPOPULATION; MALE; MYCOSIS FUNGOIDES; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN BIOPSY; T LYMPHOCYTE RECEPTOR GENE; TUMOR DIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOPSY; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 79959828262     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31820595da     Document Type: Article

References (84)

1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785. (Pubitemid 40656118)
2. Burg G, Kempf W, Cozzio A, et al. WHO/EORTC classification of cutaneous lymphomas 2005: Histological and molecular aspects. J Cutan Pathol. 2005;32:647-674. (Pubitemid 41719746)
3. Olerud JE, Kulin PA, Chew DE, et al. Cutaneous T-cell lymphoma: Evaluation of pretreatment skin biopsy specimens by a panel of pathologists. Arch Dermatol. 1992;128:501-507.
4. Kinney MC, Jones D. Cutaneous T-cell and NK-cell lymphomas: The WHO-EORTC classification and the increasing recognition of specialized tumor types. Am J Clin Pathol. 2007;127:670-686.
5. Ponti R, Quaglino P, Novelli M, et al. T-cell receptor g gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: Correlation with clinical, histological and immunophenotypical findings. Br J Dermatol. 2005;153:565-573. (Pubitemid 41248214)
6. Guitart J, Kennedy J, Ronan S, et al. Histologic criteria for the diagnosis of mycosis fungoides: Proposal for a grading system to standardize pathology reporting. J Cutan Pathol. 2001;28:174-183. (Pubitemid 32234722)
7. Massone CMD, Kodama KMD, Kerl HMD, et al. Histopathologic features of early (patch) lesions of mycosis fungoides: A morphologic study on 745 biopsy specimens from 427 patients. Am J Surg Pathol. 2005;29:550.
8. Smoller BR, Bishop K, Glusac E, et al. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol. 1995;19:1423-1430.
9. Yeh YA, Hudson AR, Prieto VG, et al. Reassessment of lymphocytic atypia in the diagnosis of mycosis fungoides. Mod Pathol. 2001;14: 285-288. (Pubitemid 32298913)
10. Pimpinelli N, Olsen EA, Santucci M, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005;53:1053-1063. (Pubitemid 41677332)
11. Gerami P, Guitart J. The spectrum of histopathologic and immunohistochemical findings in folliculotropic mycosis fungoides. Am J Surg Pathol. 2007;31:1430-1438. (Pubitemid 47329681)
12. Diwan AH, Prieto VG, Herling M, et al. Primary Sezary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism. Am J Clin Pathol. 2005;123:510-515. (Pubitemid 40418545)
13. Weiss LM, Hu E,Wood GS, et al. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med. 1985;313:539-544. (Pubitemid 15012832)
14. Wood GS, Tung RM, Heaffner AC, et al. Detection of clonal T-cell receptor g gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Investig Dermatol. 1994;103:34-41. (Pubitemid 24227566)
15. Ponti R, Fierro MT, Quaglino P, et al. TCRg-chain gene rearrangement by PCR-based GeneScan: Diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples. J Invest Dermatol. 2008;128:1030-1038. (Pubitemid 351374302)
16. Chu A, Patterson J, Berger C, et al. In situ study of T-cell subpopulations in cutaneous T-cell lymphoma. Diagnostic criteria. Cancer. 1984;54: 2414-2422. (Pubitemid 15223382)
17. Ralfkiaer E,Wantzin GL, Mason DY, et al. Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Comparison with large plaque parapsoriasis and benign chronic dermatoses. Am J Clin Pathol. 1985;84: 610-619. (Pubitemid 16235300)
18. Michie SA, Abel EA, Hoppe RT, et al. Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides. Am J Pathol. 1990;137:1447-1451.
19. Bergman R, Faclieru D, Sahar D, et al. Immunophenotyping and T-cell receptor gamma gene rearrangement analysis as an adjunct to the histopathologic diagnosis of mycosis fungoides. J Am Acad Dermatol. 1998;39:554-559. (Pubitemid 28465877)
20. Florell SR, Cessna M, Lundell RB, et al. Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Am J Clin Pathol. 2006;125:727-736.
21. Picker LJ, Weiss LM, Medeiros LJ, et al. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol. 1987;128: 181-201. (Pubitemid 17094347)
22. Stevens SR, Ke MS, Birol A, et al. A simple clinical scoring system to improve the sensitivity and standardization of the diagnosis of mycosis fungoides type cutaneous T-cell lymphoma: Logistic regression of clinical and laboratory data. Br J Dermatol. 2003;149:513-522. (Pubitemid 37281582)
23. Haynes BF, Metzgar RS, Minna JD, et al. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med. 1981;304:1319-1323. (Pubitemid 11113688)
24. Rappl G, Muche JM, Abken H, et al. CD4+CD7- T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome. J Am Acad Dermatol. 2001;44:456-461. (Pubitemid 32199965)
25. Reinhold U, Abken H, Kukel S, et al. CD7- T cells represent a subset of normal human blood lymphocytes. J Immunol. 1993;150:2081-2089. (Pubitemid 23129687)
26. Moll M, Reinhold U, Kukel S, et al. CD7-negative helper T cells accumulate in inflammatory skin lesions. J Invest Dermatol. 1994;102: 328-332. (Pubitemid 24095499)
27. Harmon CB, Witzig TE, Katzmann JA, et al. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. J Am Acad Dermatol. 1996; 35:404-410.
28. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111:3941-3967.
29. Wood B. 9-color and 10-color flow cytometry in the clinical laboratory. Arch Pathol Lab Med. 2006;130:680-690. (Pubitemid 43736872)
30. Jamal S, Picker LJ, Aquino DB, et al. Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach. Am J Clin Pathol. 2001;116:512-526. (Pubitemid 34450285)
31. Kuchnio M, Sausville EA, Jaffe ES, et al. Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of Tcell receptor expression. Am J Clin Pathol. 1994;102:856-860.
32. Karube K, Aoki R, Nomura Y, et al. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: Analysis of 490 cases. Pathol Int. 2008;58:89-97.
33. Edelman J, Meyerson HJ. Diminished CD3 expression is useful for detecting and enumerating Sezary cells. Am J Clin Pathol. 2000;114: 467-477. (Pubitemid 33049683)
34. Lima M, Almeida J, dos Anjos Teixeira M, et al. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sezary's syndrome. Haematologica. 2003;88:874-887. (Pubitemid 37128087)
35. Bogen SA, Pelley D, Charif M, et al. Immunophenotypic identification of Sezary cells in peripheral blood. Am J Clin Pathol. 1996;106:739-748. (Pubitemid 27009491)
36. Jones D, Dang NH, Duvic M, et al. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol. 2001;115:885-892. (Pubitemid 32476716)
37. Washington L, Huh Y, Powers L, et al. A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clin Pathol. 2002;2:5.
38. Morice WG, Katzmann JA, Pittelkow MR, et al. A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCRPCR in qualitative and quantitative assessment of peripheral blood involvement by Sezary syndrome. Am J Clin Pathol. 2006;125:364-374. (Pubitemid 43327705)
39. Kelemen K, Guitart J, Kuzel TM, et al. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sezary syndrome. Am J Clin Pathol. 2008;129:146-156. (Pubitemid 352038603)
40. Kussick SJ, Fromm JR, Rossini A, et al. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol. 2005;124:170-181. (Pubitemid 41060126)
41. Kussick SJ, Wood BL. Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non- CML myeloproliferative disorders. Am J Clin Pathol. 2003;120:854-865. (Pubitemid 37486740)
42. Sprouse JT,Werling R, Hanke D, et al. T-cell clonality determination using polymerase chain reaction (PCR) amplification of the T-cell receptor gamma-chain gene and capillary electrophoresis of fluorescently labeled PCR products. Am J Clin Pathol. 2000;113:838-850. (Pubitemid 33051520)
43. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: A proposal of the international society for cutaneous lymphomas (ISCL) and the cutaneous lymphoma task force of the European organization of research and treatment of cancer (EORTC). Blood. 2007;110:1713-1722. (Pubitemid 47443880)
44. Balfour EM, Glusac EJ, Heald P, et al. Sezary syndrome: Cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificity. J Cutan Pathol. 2003;30:437-442. (Pubitemid 36920924)
45. Oshtory S, Apisarnthanarax N, Gilliam AC, et al. Usefulness of flow cytometry in the diagnosis of mycosis fungoides. J Am Acad Dermatol. 2007;57:454.
46. GorczycaW,Weisberger J, Liu Z, et al. An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Cytometry. 2002;50: 177-190. (Pubitemid 37517317)
47. Ichimura K, Kagami Y, Suzuki R, et al. Phenotypic analysis of peripheral T/NK cell lymphoma: Study of 408 Japanese cases with special reference to their anatomical sites. Pathol Int. 2003;53:333-344. (Pubitemid 36859624)
48. Kallinich T, Muche JM, Qin S, et al. Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol. 2003;121:1045-1052. (Pubitemid 37430972)
49. Wu H, Smith M, Millenson MM, et al. Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesions. J Invest Dermatol. 2003; 121:1522.
50. Lima M, Velho G, Alves R, et al. Atopic dermatitis-like nonerythrodermic leukemic variant of CD3-/+dim CD4+ cutaneous T-cell lymphoma preceded by cutaneous papular xanthomatosis. Leuk Lymphoma. 2004;45:597-603. (Pubitemid 38196045)
51. Yagi H, Seo N, Ohshima A, et al. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: Immunohistochemical staining and in vitro chemotactic assay. Am J Surg Pathol. 2006;30: 1111-1119. (Pubitemid 44299344)
52. Dunphy CH, Nahass GT. Primary cutaneous T-cell-rich B-cell lymphomas with flow cytometric immunophenotypic findings. Report of 3 cases and review of the literature. Arch Pathol Lab Med. 1999;123:1236-1240.
53. Abel EA, Wood GS, Hoppe RT, et al. Expression of Leu-8 antigen, a majority T-cell marker, is uncommon in mycosis fungoides. J Invest Dermatol. 1985;85:199-202. (Pubitemid 15227246)
54. Borowitz MJ, Weidner A, Olsen EA, et al. Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: Cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease. Leukemia. 1993;7:859-863. (Pubitemid 23210865)
55. Wallace DL, Beverley PC. Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunology. 1990;69:460-467. (Pubitemid 20076528)
56. Scala, E, Russo, G, Cadoni S, et al. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion. J Invest Dermatol. 1999;113:622-627. (Pubitemid 29489627)
57. Santucci M, Biggeri A, Feller AC, et al. Efficacy of histologic criteria for diagnosing early mycosis fungoides: An EORTC cutaneous lymphoma study group investigation. Am J Surg Pathol. 2000;24:40.
58. Hodak E, David M, Maron L, et al. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: An immunohistochemical variant of mycosis fungoides. J Am Acad Dermatol. 2006;55:276-284. (Pubitemid 44056178)
59. Whittam LR, Calonje E, Orchard G, et al. CD8-positive juvenile onset mycosis fungoides: An immunohistochemical and genotypic analysis of six cases. Br J Dermatol. 2000;143:1199-1204. (Pubitemid 32052755)
60. Fierro MT, Novelli M, Savoia P, et al. CD45RA+ immunophenotype in mycosis fungoides: Clinical, histological and immunophenotypical features in 22 patients. J Cutan Pathol. 2001;28:356-362. (Pubitemid 32667006)
61. Dummer R, Kamarashev J, Kempf W, et al. Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: A CD8+ variant of mycosis fungoides? Arch Dermatol. 2002;138:199-203. (Pubitemid 34160394)
62. Lu D, Patel KA, Duvic M, et al. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas. J Cutan Pathol. 2002;29: 465-472. (Pubitemid 35034457)
63. El Shabrawi-Caelen L, Cerroni L, Medeiros LJ, et al. Hypopigmented mycosis fungoides: Frequent expression of a CD8+ T-cell phenotype. Am J Surg Pathol. 2002;26:450-457. (Pubitemid 34280117)
64. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Cancer. 2003;97:610-627.
65. Ben-Amitai D, David M, Feinmesser M, et al. Juvenile mycosis fungoides diagnosed before 18 years of age. Acta Derm Venereol. 2003;83:451-456. (Pubitemid 37475788)
66. Wain EM, Orchard GE, Mayou S, et al. Mycosis fungoides with a CD56+ immunophenotype. J Am Acad Dermatol. 2005;53:158-163.
67. Klekotka PA, Faulkner-Jones B, Heffernan MP. A case of CD56+ mycosis fungoides. Arch Dermatol. 2006;142:1370-1372.
68. Horst BA, Kasper R, LeBoit PE. CD4+, CD56+ mycosis fungoides: Case report and review of the literature. Am J Dermatopathol. 2009;31:74-76.
69. Nuckols JD, Shea CR, Horenstein MG, et al. Quantitation of intraepidermal T-cell subsets in formalin-fixed, paraffin-embedded tissue helps in the diagnosis of mycosis fungoides. J Cutan Pathol. 1999;26:169.
70. Ortonne N, Buyukbabani N, Delfau-Larue M-H, et al. Value of the CD8- CD3 ratio for the diagnosis of mycosis fungoides. Mod Pathol. 2003;16: 857-862. (Pubitemid 37152014)
71. Ralfkiaer E, Wollf-Sneedorff A, Thomsen K, et al. Immunophenotypic studies in cutaneous T-cell lymphomas: Clinical implications. Br J Dermatol. 1993;129:655-659. (Pubitemid 24003549)
72. Smoller BR, Bishop K, Glusac EJ, et al. Lymphocyte antigen abnormalities in inflammatory dermatoses. Appl Immunohistochem. 1995;3:127-131.
73. Izban KF, Hsi ED, Alkan S. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections. Mod Pathol. 1998;11: 978-982. (Pubitemid 28487218)
74. Muche JM, Lukowsky A, Heim J, et al. Demonstration of frequent occurrence of clonal T cells in the peripheral blood but not in the skin of patients with small plaque parapsoriasis. Blood. 1999;94:1409-1417. (Pubitemid 29380422)
75. Vakeva L, Sarna S, Vaalasti A, et al. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides. Acta Derm Venereol. 2005;85:318-323. (Pubitemid 41113513)
76. Stachowitz S, Mempel M, Schmockel C, et al. Variable course of patients with plaque psoriasis: Lack of transformation into tumorous mycosis fungoides. Blood. 2000;95:3635-3636. (Pubitemid 30428505)
77. Lazar AP, Caro WA, Roenigk HH Jr, et al. Parapsoriasis and mycosis fungoides: The Northwestern University experience, 1970 to 1985. J Am Acad Dermatol. 1989;21:919-923. (Pubitemid 19268633)
78. Kikuchi A, NakaW, Harada T, et al. Parapsoriasis en plaques: Its potential for progression to malignant lymphoma. J Am Acad Dermatol. 1993;29: 419-422. (Pubitemid 23260129)
79. Lambert WC, Everett MA. The nosology of parapsoriasis. J Am Acad Dermatol. 1981;5:373-395. (Pubitemid 12247081)
80. Klemke C-D, Dippel E, Dembinski A, et al. Clonal T cell receptor gammachain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides. J Pathol. 2002;197:348-354. (Pubitemid 34778305)
81. Joly P, Benoit-Corven C, Baricault S, et al. Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: Results from a case-control study. J Invest Dermatol. 2007;127: 2766-2771. (Pubitemid 350134830)
82. Bernengo MG, Novelli M, Quaglino P, et al. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Br J Dermatol. 2001;144:125-135. (Pubitemid 32154603)
83. Wang S, Li N, Heald P, et al. Flow cytometric DNA ploidy analysis of peripheral blood from patients with Sézary syndrome. Am J Clin Pathol. 2004;122:774-782.
84. Fierro MT, Novelli M, Quaglino P, et al. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma. Dermatology. 2008;216:213-221. (Pubitemid 351416720)